Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: The case for

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 243-250

  Moayyedi, P ^a   Axon, A T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST;

COMMUNITY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DYSPEPSIA; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; MORTALITY; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH CARCINOMA;

EID: 0031950978     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011674     Document Type: Review

References (53)

1. Imperiale TF, Speroff T, Cebul RD, McCullough AJ. A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med 1995; 123: 665-72
2. O'Brien B, Goeree R, Mohamed AH, Hunt R. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med 1995; 155: 1958-64
3. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110: 72-83
4. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123: 260-8
5. Briggs AH, Sculpher MJ, Logan RP, Aldous J, Ramsay ME, Baron JH. Cost effectiveness of screening for and eradication of Helicobacter pylori in the management of dyspeptic patients under 45 years of age. BMJ 1996; 312: 1321-5
6. Moayyedi P, Dixon MF. Significance of Helicobacter pylori infection and gastric cancer: implications for screening. Gastrointest Endosc Clin N Am 1997; 7: 47-64.
7. Her Majesty's Stationery Office. Statistics of prescriptions dispensed in the Family Health Service Authorities: England 1984-94. Statistical Bulletin 9515. London: HMSO, 1995
8. Jones RH, Lydeard SE, Hobbs FD et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5
9. OPCS morbidity statistics in general practice. 4th National Survey (1991-1992). London: HMSO, 1996
10. Scott BB. Gastroenterology in the Trent Region in 1992 and a review of changes since 1975. Gut 1995; 36: 468-72
11. Axon ATR. O'Morain CA, Bardhan KD et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997; 14: 565-8
12. Hentschel E, Brandstatter G, Dragosics B et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12
13. Langman MJS, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual anti-inflammatory drugs. Lancet 1994; 343: 1075-8
14. Hosking SW, Yung MY, Chung SC, Li AKC. Differing prevalence of Helicobacter pylori in bleeding and nonbleeding ulcers [abstract]. Gastroenterology 1992; 102: A90
15. Jensen DM, You S, Pelayo E, Jensen ME. The prevalence of Helicobacter pylori and NSAID use in patients with severe UGI hemorrhage and their potential role in recurrence of ulcer bleeding [abstract]. Gastroenterology 1992; 102: A90
16. Sebastian M, Prem Chandra VP, Elashaal IM, Sim JW. Helicobacter pylori infection in perforated peptic ulcer disease. Br J Surg 1995; 82: 360-2
17. Laine LA. Helicobacter pylori and complicated ulcer disease. Am J Med 1996; 100: 52S-9S
18. Forman DL, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from prospective investigation. BMJ 1991; 302: 1302-5
19. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31
20. Nomura A, Stemmermann GN, Chyou P-H, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6
21. Forman D, Webb P, Parsonnet J. H. pylori and gastric cancer [letter]. Lancet 1994; 343: 243-4
22. IARC Monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. In: International Agency for Research on Cancer Monograph 61. Lyon: IARC, 1994; 177-240
23. Sobala GM, Schorah CJ, Shires S et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038-41
24. Lynch DA, Mapstone NP, Clarke AM et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995; 36: 346-50
25. Uemura N, Mukai T, Okamoto S et al. Helicobacter pylori eradication inhibits the growth of intestinal type of gastric cancer in initial stage [abstract]. Gastroenterology 1996; 110: A282
26. Office of Population Census and Surveys. Mortality statistics: cause - review of the Register General on deaths by cause, sex and age in England and Wales, 1993. London: HMSO, 1995
27. Axon ATR, Forman D. Helicobacter gastro-duodenitis, a serious infectious disease. BMJ 1997; 314: 1430-1
28. Patel P, Mendall MA, Carrington D et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 31: 711-4
29. OsseiGernig, Moayyedi P, et al. Eur Heart J 1998; in press
30. Rathbone B, Martin D, Stephens J, Thompson JR, Samani NJ. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart 1996; 76: 308-11
31. 13C-urea breath test? Eur J Gastroenterol Hepatol 1997; 9: 275-7
32. Wilcox MH, Dent TH, Hunter JO et al. Accuracy of serology for the diagnosis of Helicobacter pylori infection - a comparison of eight kits. J Clin Pathol 1996; 49: 373-6
33. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT . Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109: 136-41
34. Moayyedi P, Carter AM, Catto A, Heppell RM, Grant PJ, Axon ATR. Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ 1997; 314: 119
35. Stone MA, Mayberry JF, Wicks ACB et al. Near patient testing for Helicobacter pylori: a detailed evaluation of the Cortecs Helisal Rapid Blood test. Eur J Gastroenterol Hepatol 1997; 9: 257-60
36. Axon ATR, Moayyedi P. Eradication of Helicobacter pylori: omeprazole in combination with antibiotics. Scand J Gastroenterol 1996; 215 (Suppl): 82-9
37. Bazzoli F, Zagari RM, Fossi S et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994; 6: 773-7
38. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40
39. Labenz J, Stolte M, Ruhl GH et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 9-11
40. General practitioner remuneration for cervical screening in the United Kingdom. Leeds: FHSA, 1996
41. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348: 150-4
42. Department for Health and Social Security. Breast Cancer Screening. Report to the Health Minister of England, Wales, Scotland and Northern Ireland by a Working Group chaired by Professor Sir Patrick Forrest. London: HMSO, 1986
43. Teare JP, Booth JC, Brown JL, Martin J, Thomas HC. Pseudomembranous colitis following clarithromycin therapy. Eur J Gastroenterol Hepatol 1995; 7 : 275-7
44. Leeds Healthcare PACT Data, 1994
45. Corthesy-Theulaz I, Porta N, Glauser M et al. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995; 109: 115-21
46. Lee A. Prevention of Helicobacter pylori infection. Scand J Gastroenterol 1996; 215 (Suppl): 11-5
47. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996; 215: 48-51
48. Moayyedi P, Tompkins DS, Barrowclough S et al. Outcome of Helicobacter pylori eradication in omeprazole, clarithromycin and tinidazole treatment failures [abstract]. Gut 1995; 27 (Suppl 2): A32
49. Wilkinson C, Jones MJ, McBride J. Anxiety caused by abnormal results of cervical smear test: a controlled trial. BMJ 1990; 300: 440
50. Blaser MJ. Helicobacter pylori eradication and its implications for the future. Aliment Pharmacol Ther 1997; 11 (Suppl 1): 103-7
51. Labenz J, Tillenburg U, Peitz U, Borsch G. Long-term consequences of Helicobacter pylori eradication: clinical aspects. Scand J Gastroenterol 1996; 215 (Suppl): 111-5
52. Department of Health. Form KH09 1995-6
53. United Leeds Hospital Trust estimates on cost of procedures 1997